Search Browse Earnings

Seres Therapeutics, Inc.

Nasdaq:MCRB

Pharmaceutical Preparations·CAMBRIDGE, MA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$11.9M

-56.2% YoY

FY 2022

Adj. EBITDA

-$188.9M

-1587.4% margin

FY 2025

Net Income

-$113.7M

-955.9% margin

FY 2025

EPS (Diluted)

-$17.77

FY 2025

Stock Price

$8.63

-4.6%

2026-03-13

52W Range

$6.53 – $29.98

P/E Ratio

-0.5x

Market Cap

$82.7M

Cash

$30.8M

FY 2025

Total Debt

$110.5M

FY 2023

Net Debt

$79.7M

FY 2023

Enterprise Value

$162.4M

Debt / EBITDA

-0.4x

FY 2022

EV / EBITDA

-0.9x

Employees

—